WEBINAR DETAILS

Proactive vs reactive therapeutic drug monitoring in Inflammatory Bowel Disease (IBD)

Biohit Healthcare Ltd

This webinar will brought together Jimmy Limdi – Consultant Gastroenterologist and Head of the Section for IBD at the Northern Care Alliance NHS Foundation Trust – and Christian Selinger – Consultant Gastroenterologist at Leeds Teaching Hospitals NHS Trust – to discuss proactive versus reactive therapeutic drug monitoring (TDM) for inflammatory bowel disease (IBD). The main discussion was moderated by The Clinical Services Journal, where the two speakers deliberated about the benefits and limitations of using proactive and reactive TDM, with details of their trusts’ practices and case studies.

A live Q&A was held after where attendees could raise any questions.

  • Date
  • Duration

Latest Issues

CSC Autumn Study Day 2024

Crowne Plaza Birmingham NEC
14th October 2024

BAUN 2024 Annual Conference

ACC, Liverpool
3rd - 5th November 2024

The AfPP Roadshow - Belfast

ICC Belfast
9th November 2024

IDSc Annual Conference 2024

Hilton Birmingham Metropole Hotel
26th - 27th November 2024

IV Forum 2024

Birmingham Conference & Events Centre (BCEC)
Wednesday 4th December 2024

The AfPP Roadshow - Leeds

TBA, Leeds
7th December 2024